Alexander Nowak
Stock Analyst at Craig-Hallum
(2.69)
# 1,989
Out of 5,051 analysts
45
Total ratings
44.44%
Success rate
7.17%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $9.79 | +124.72% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $199.92 | -21.47% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $7.38 | +130.35% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $27.37 | +108.26% | 6 | Sep 5, 2024 | |
| CELC Celcuity | Assumes: Buy | $25 → $27 | $74.59 | -63.80% | 2 | May 16, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $16.53 | -9.26% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $6.65 | +20.30% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $1.70 | +958.82% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $14.67 | +240.83% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $280 → $160 | $13.59 | +1,077.34% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $69.63 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.73 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.81 | +291.46% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $59.94 | +83.52% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $6.73 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $2.43 | +12,245.68% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $10.00 | +180.00% | 1 | Aug 31, 2020 |
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $9.79
Upside: +124.72%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $199.92
Upside: -21.47%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $7.38
Upside: +130.35%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $27.37
Upside: +108.26%
Celcuity
May 16, 2024
Assumes: Buy
Price Target: $25 → $27
Current: $74.59
Upside: -63.80%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $16.53
Upside: -9.26%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $6.65
Upside: +20.30%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $1.70
Upside: +958.82%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $14.67
Upside: +240.83%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $280 → $160
Current: $13.59
Upside: +1,077.34%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $69.63
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.73
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.81
Upside: +291.46%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $59.94
Upside: +83.52%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $6.73
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $2.43
Upside: +12,245.68%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $10.00
Upside: +180.00%